Calmlocket Sat 06-Nov-21 20:24:52
The new covid pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease. Patients with mild-to-moderate COVID-19 would take four pills of the drug, known molnupiravir, twice a day for five days.
I researched this drug molnupiravir and was alarmed to read about the potential dangers the antiviral drug molnupiravir could unleash by supercharging new SARS-CoV-2 variants. Theres a possibility that molnupiravir could lead to cancerous tumors in those patients and birth defects in the unborn.